Doctors Without Borders Welcomes Johnson & Johnson Price Cut on Lifesaving Tuberculosis Drug As An Important Step Forward
July 07, 2020
July 07, 2020
NEW YORK, July 7 -- The Doctors Without Borders/Medecins Sans Frontieres issued the following news:
The international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) welcomes Johnson & Johnson's (J&J) announcement to reduce the price of its tuberculosis (TB) drug bedaquiline to $1.50 per day. Governments must now urgently scale up the use of the treatment as a core part of drug-resistant TB (DR-TB) regimens, MSF said.
The . . .
The international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) welcomes Johnson & Johnson's (J&J) announcement to reduce the price of its tuberculosis (TB) drug bedaquiline to $1.50 per day. Governments must now urgently scale up the use of the treatment as a core part of drug-resistant TB (DR-TB) regimens, MSF said.
The . . .